MedPath

Depression-intervention study for optimization of reconvalesence after stroke

Not Applicable
Recruiting
Conditions
I63.9
I61.9
Cerebral infarction, unspecified
Intracerebral haemorrhage, unspecified
Registration Number
DRKS00033792
Lead Sponsor
niversitätsklinikum Augsburg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
75
Inclusion Criteria

Patients with acute ischemic or hemorrhagic stroke; Age = 18 years; Signed informed consent; signs of depression (Patient Health Questionnaire (PHQ)-9 = 15)

Exclusion Criteria

Malignancy or other severe disease with life-expectancy less than the expected duration of the trial; Inability of giving informed consent (e.g. aphasia, dementia); Patients with legal representatives, Premorbid modified Rankin Scale (mRS) > 2

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction of depressive symptoms assessed by PHQ-9 from baseline (V1) to 90 (V3) and 365 (V5) days after the index event.
Secondary Outcome Measures
NameTimeMethod
Favorable functional outcome (mRS =2 and change in mRS) 90 and 365 days after the index event; Depressive symptoms during the study period assessed with the Montgomery–Åsberg Depression Rating Scale (MADRS); Quality of life (assessed by EuroQoL 5-Dimension (EQ-5D); Overall functioning (GAF) und psychiatric disease severity (CGI) during the study period; Incidence of major cardiovascular events defined as nonfatal stroke (ischemic or hemorrhagic), nonfatal myocardial infarction (including acute coronary syndrome requiring emergency vascularization), and vascular death (i.e. sudden cardiac death and death from acute myocardial infarction, ischemic or hemorrhagic stroke, heart failure, cardiovascular procedures, pulmonary embolism, or peripheral artery disease) within one year of the index event; Recurrent ischemic or hemorrhagic stroke and Transient ischemic attack within one year of the index-event; All-cause mortality at 12 months.
© Copyright 2025. All Rights Reserved by MedPath